After years of work, our team started to develop an engineered virus armed with advanced genetic circuits to fight against cancer as a part of host immune system. We call this next-generation intelligent oncolytic virus, Intellivir. Categorized as an immunotherapy and in the class of oncolytic virotherapy, Intellivir is going to be the first application of synthetic viruses armed with advanced genetic circuits we've been developing for a long time and will have a direct impact on our lives.
We are happy to announce that with the introduction of Intellivir, GEEN Biotechnology has now completely become a therapeutics company and focused on developing Intelligent Oncolytic Viruses (iOVs) using our previous
experience on GeenOS that lead to great progress on genetic circuits, directed evolution, computer simulation and synthetic virology.